WisdomTree BioRevolution Fund (WDNA)
- Previous Close
13.26 - Open
12.55 - Bid 6.15 x 800
- Ask 18.43 x 800
- Day's Range
12.15 - 12.15 - 52 Week Range
11.20 - 17.22 - Volume
406 - Avg. Volume
1,150 - Net Assets 1.98M
- NAV 13.05
- PE Ratio (TTM) 12.62
- Yield 0.81%
- YTD Daily Total Return -9.35%
- Beta (5Y Monthly) 1.18
- Expense Ratio (net) 0.45%
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
WisdomTree
Fund Family
Health
Fund Category
1.98M
Net Assets
2021-06-01
Inception Date
Performance Overview: WDNA
View MoreTrailing returns as of 5/5/2025. Category is Health.
People Also Watch
Holdings: WDNA
View MoreTop 10 Holdings (23.33% of Total Assets)
Sector Weightings
Related ETF News
View More
Research Reports: WDNA
View MoreBloom Energy Earnings: 2025 Guidance Reiterated as Tariff Effects Are Limited; CFO Departs
Bloom Energy designs, manufactures, sells, and installs solid-oxide fuel cell systems ("Energy Servers") for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. In 2021, the company announced plans to leverage its technology and enter the electrolyzer market. Bloom primarily sells its systems in the United States and internationally.
RatingPrice TargetBloom Energy Earnings: 2025 Guidance Reiterated as Tariff Effects Are Limited; CFO Departs
Bloom Energy designs, manufactures, sells, and installs solid-oxide fuel cell systems ("Energy Servers") for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. In 2021, the company announced plans to leverage its technology and enter the electrolyzer market. Bloom primarily sells its systems in the United States and internationally.
RatingPrice TargetLowering target price to $33.00
PROTO LABS INC has an Investment Rating of HOLD; a target price of $33.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $40.00
PROTO LABS INC has an Investment Rating of HOLD; a target price of $40.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target